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INTRODUCTION.
Renal cell carcinoma (RCC) is the most common type of kidney cancer and is considered the most lethal of all genitourinary cancers. The majority of RCC diagnoses are of clear cell subtype (ccRCC) and accounts for 80-90% of renal epithelial malignancies.(1) Alarmingly, up to 20% of patients present with locally advanced or metastatic disease and more than a third of patients with early-stage disease treated with curative intent will face metastatic recurrence. ( Macroautophagy (hereafter referred to as autophagy) is a highly conserved catabolic process that assures cellular homeostasis. Canonical autophagy is characterized by the formation of a phagophore membrane that elongates and closes to form a double-membrane vesicle called autophagosome (AP). The enclosed intracellular components are delivered to lysosomes for degradation. This process can be dissected in four steps; 1) initiation; 2) nucleation; 3) maturation and 4) fusion. The initiation and nucleation phases are essential for phagophore formation and are regulated by the complex ULK1-mATG13-FIP200 and by a complex including the class 3 phosphatidylinositol-3-kinase (VPS34), p150, ATG14L and Beclin-1, respectively. The maturation phase, consisting in phagophore elongation, curvature and closure is regulated by ubiquitin-like conjugation systems ensuring the lipidation of the AP marker LC3 (LC3-II) and its insertion in the membrane via the complex ATG12-ATG5-ATG16L1. The adaptor protein p62/sequestosome-1(SQSTM1) binds LC3-II and facilitates autophagic degradation of ubiquitinated cargo. Its increased levels often correlate with autophagy inhibition.
In cancer, autophagy can serve as a survival pathway, especially in advanced stages. It is thought to promote tumor growth and progression by enhancing cancer cells' survival in harsh conditions such as hypoxia and nutrient limitations. (8) In this context, suppressing autophagy has shown promise as a therapeutic modality to sensitize cancer cells to conventional and targeted therapies.(9) However, given the multifarious behaviors of each cancer, fine-tuning specific mechanisms of autophagic suppression remains difficult. Indeed, autophagy and its interconnected pathways seem to be uniquely regulated in each cancer. Thus, novel autophagymodulating tools are needed to unravel unique mechanistic insights existing between autophagy, endocytosis and vesicular trafficking pathways. One of the first studies to suggest autophagymodulation as a potential therapy for VHL-deficient RCCs did so by identifying STF-62247, a compound demonstrating selectivity for RCC cells harboring VHL mutations. (10) Considering that the extensive study of autophagy was not the primary goal of this previous paper, this present work aimed at an in-depth study of STF-62247's effects on the autophagic flux. We show that STF-62247 is a blocker of late stages of autophagy by targeting lysosomal physiology. We highlight STF-62247's lysosomotropic properties causing enlargement of endo-lysosomal compartments and vesicle trafficking defects. Finally, our study elucidates a potential new role for VHL in maintaining lysosomal integrity and highlights its potential usage as a powerful new tool for the study of vesicle trafficking and lysosome-related research.
RESULTS.

STF-62247 blocks late stages of autophagy independently of VHL status.
Three cell line models have been chosen for this study; VHL-mutated ccRCC cell line (RCC4), its subclone counterpart stably transfected with an expression vector encoding VHL (RCC4 VHL) and a cell line containing endogenous VHL in which canonical autophagy has been extensively studied (HeLa). (11) (12) (13) (14) To assess the selective properties of STF-62247 (STF), the sensitivity of all three cell lines has been tested by XTT viability assays ( Fig.1A ). VHL-mutated RCC4 cells are significantly more sensitive to the small compound compared to VHL-containing cell lines RCC4 VHL and HeLa. It should be noted that HeLa cells remain relatively unaffected when compared to RCC4 VHL cells, even at high STF concentrations such as 10 and 20 M ( Fig.1A) . In addition to the selective properties of STF, a striking phenotype is observed following treatment; the formation of large translucid intracytoplasmic vacuoles (Fig. 1B) . The vacuolar phenotype of VHL-containing cell models (RCC4VHL, HeLa) remains controlled with modest vacuole sizes whereas VHL-defective RCC4 cells present continuously expanding vacuoles ( Fig. 1B) .
In order to evaluate STF-62247's effect on autophagy and to identify possible related differences that would correlate with VHL-dependent viability, LC3-turnover assays were performed ( Fig.   1C-1E ). Levels of LC3-II and p62 were measured by immunoblot analysis in response to STF and to a saturating concentration of the lysosomal-disrupting agent Bafilomycin A1 (BAF) either alone, or in combination with STF. BAF, a known inhibitor of vacuolar H+ ATPase pump (V-ATPase) is used as a control for its known inhibitory effects on autophagy efflux. (15) (16) (17) BAF control alone resulted in significant accumulation of LC3-II and p62 levels in every cell line model, as expected ( Fig.1C-1E ). The combination of BAF plus STF did not show an additive effect on LC3-II levels compared to BAF alone in neither VHL-mutated RCC4 cells nor in cell lines containing a functioning gene, RCC4 VHL and HeLa (Fig. 1C-1E ). To confirm these results, cell lines expressing stable GFP-LC3 were generated (RCC4.GFP-LC3 and RCC4VHL.GFP-LC3) and puncta formation by confocal microscopy was quantified ( Fig.1F-1H ). Importantly, a lipidation-defective GFP-LC3 mutant where glycine 120 is mutated to alanine (RCC4 GFP-LC3_mut and RCC4VHL GFP-LC3_mut) was utilized as a specificity control in order to avoid possible aggregation of the chimera, unrelated to autophagy that would be due to high levels of expression ( Fig. 1F ). (18, 19) In response to BAF or STF, GFP-LC3-mut models show no puncta formation confirming the functionality of the chimeric models ( Fig. 1F) .
In agreement with immunoblot analyses, combination treatments of BAF plus STF did not result in an additional increase in GFP-LC3 puncta compared to BAF treatment alone in both RCC4.GFP-LC3 and RCC4VHL.GFP-LC3 models ( Fig. 1G-1H ). Together, these observations reveal STF-62247 to be a blocker of autophagy rather than an inducer, as was previously described. (10, 20, 21) Furthermore, these results strongly suggest that this compound blocks terminal stages of autophagy independently of VHL status.
Long-term STF-62247 treatment decreases the number of endo-lysosomal vesicles in VHL-
mutated RCC4 cells.
To further evaluate the effects of STF-62247 on the autophagic flux, a tandem monomeric mCherry-GFP-tagged LC3 was stably expressed in RCC4, RCC4VHL and HeLa cell lines ( Fig.2A-2C ). Quickly, yellow fluorescence is associated with autophagic vesicles (AV) while red fluorescence alone decorates lower-pH organelles such as autolysosomes (AL). (22, 23) In accordance with the above-mentioned GFP-LC3 puncta count, combinatory treatment of BAF plus STF did not show any additive effects in the numbers of autophagic vesicles (Fig 1C-1E and 2A-2C). Interestingly, STF treatment alone increased the numbers of autophagic vesicles in all three cell lines but not those of autolysosomes, confirming a block in the flux ( Fig.2A-2C ). In fact, the number of autolysosomes remained relatively unchanged in VHL-mutated RCC4 cells whereas a significant decrease in autolysosomes was observed in VHL-proficient cell lines ( Fig.2B, 2C) . To be rigorous, levels of endogenous LC3 and LAMP-1 (marker of endolysosomal structures) were also quantified by immunofluorescence following a prolonged STF treatment ( Fig.2D, 2E) . In response to 72 hr of STF treatment, VHL-defective RCC4 cells do not restore their levels of endo-lysosomal structures and accumulate APs ( Fig. 2D, 2E ).
Contrastingly and in accordance with VHL-proficient RCC cells' capacity to overcome the vacuolization phenotype, no accumulation of APs is observed after 72 hr of STF treatment and the number of LAMP-1 positive structures is maintained ( Fig. 2D, 2E ). Confirming LC3turnover assays, these results show that STF-62247 blocks later stages of autophagy and leads to a reduction in the number of endo-lysosomes in VHL-mutated RCC4 cells.
Upstream signaling and canonical formation of autophagosomes are not affected by STF-
62247.
Small molecules and diverse synthetic compounds have already been reported to be able to simultaneously block later stages of autophagy and induce AP formation. (24) (25) (26) (27) (28) For this reason, initial steps of AP biogenesis as well as upstream signaling cascades leading to autophagy initiation have been explored in order to fully study STF-62247's effects on this pathway. The class III phosphatidylinositol 3-kinase (VPS34) is responsible for the synthesis of phosphatidylinositol-3-phosphate (PI(3)P) at the AP precursor membranes and local increases in PI(3)P recruits specific autophagic effectors such as WD-repeat protein interacting with phosphoinositides 1 (WIPI-1 /Atg18). (23, (29) (30) (31) WIPI-1 puncta formation was visualized and quantified in order to explore STF's effects on early phagophore formation ( Fig. 3A, 3B ). As expected, control starvation conditions (EBSS) increased the number of WIPI-1 puncta, indicative of autophagy initiation in both VHL-mutated and -proficient cell models (Fig 3A, 3B) .
STF treatment alone or in combination with starvation conditions however, did not increase WIPI-1 puncta formation in either cell models when compared to DMSO or EBSS controls, respectively ( Fig. 3A,3B ). Downstream of WIPI-1 recruitment, the conjugation of ATG5-ATG12 was measured by immunoblot assays (Fig. 3C) . Measuring free-ATG12 and conjugated ATG5-ATG12 is an informative technique to assess novel AP formation. Thus, conjugated ATG5-ATG12 was quantified at an early and a late time point (8 hr and 48 hr STF treatment) in VHL-defective RCC4 cells and VHL-proficient cell lines ( Fig. 3C) . Coinciding with WIPI-1 puncta count, no significant increase in ATG5-ATG12 conjugation was measured in RCC4, RCC4VHL or in HeLa cells at an early time point ( Fig. 3C) . In fact, the 48 hr-time point shows a decrease in ATG5-ATG12 conjugation in RCC4 VHL cells while no significant changes are reported in the VHL-defective RCC4 cells and in HeLa (Fig. 3C) . These results indicate that STF-62247 does not affect early steps of canonical autophagosome formation.
A major suppressive regulator of canonical autophagy is the mammalian target of rapamycin (mTOR) complex 1 (mTORC1), activated at the lysosomal surface. (32, 33) Our previous study investigating STF-62247 by quantitative proteomics had highlighted a difference in mTOR activation between VHL-proficient and -deficient cell models in response to prolonged STF treatment times. Indeed, we highlighted the ability of VHL-proficient cells to restore mTOR activity following prolonged exposition to STF-62247 compared to VHL-mutated RCC4 cells. (34) To characterize earlier effects of STF on this signaling, immunoblot analyses were performed to measure phosphorylation states of mTOR and of its downstream effector RPS6KB1/p70S6 kinase in response to a 4 hr STF treatment ( Fig. 3D) . Control starvation conditions (EBSS) not only reduced the phosphorylation of P-mTOR (S2448), but completely inhibited the phosphorylation levels of P-p70S6K (T389) by mTOR ( Fig. 3D) . However, at variance with previously published prolonged STF-treatment times, 4 hr STF treatment alone or in combination with starvation conditions did not alter the levels of total mTOR and p70S6K or of their phosphorylation levels ( Fig. 3D) .
Next, total and phosphorylated states of AMP-activated protein kinase (AMPK), a multimeric serine/threonine protein kinase that acts as a fine-tuned sensor of energetic levels in the cell was measured in response to STF treatment. Phosphorylation of the conserved threonine residue (p-AMPK T172) is a prerequisite for its activity. (35) Consequently, activated AMPK inhibits mTOR function and acts as an inducer of autophagy via activation of the ULK1-mATG13-FIP200 complex. No significant alterations of total AMPK or p-AMPK T172 were observed in response to STF alone or when combined with starvation conditions in either VHL-mutated RCC4 cells or in VHL-proficient RCC4 VHL and Hela. These results indicate that while STF-62247 blocks later stages of autophagy, this small compound does not simultaneously affect upstream signaling or the canonical formation of autophagosomes.
CRISPR/Cas9 knock-outs of essential ATG genes indicate a partial role for autophagy in
STF-62247 signaling
Stable CRISPR/Cas9 knockout (KO) cell models of essential autophagy related genes (ATG) were established in VHL-mutated and -proficient cell lines to inhibit early steps of autophagy initiation and to elucidate the importance of this pathway in STF's signaling. KOs of BECN-1/Beclin-1 and ATG5 were chosen to suppress autophagy as they play essential roles in the nucleation and maturation steps, respectively. (Fig. 4A-4F ) XTT viability assays were performed in order to study the effects of these KOs on the sensitive VHL-mutated RCC4 cells in response to increasing concentrations of STF (Fig 4A, 4B) . Impeding autophagy initiation in VHLmutated RCC4 cells by crispr.Beclin-1 or crispr.ATG5 both rescued their viability and rendered them up to 56% and 46% more resistant at the highest STF concentration, respectively. Although an increase in viability is observed in VHL-defective RCC4 cells, this rescue is not found in VHL-proficient cell models, in fact it remains unchanged ( Fig. 4C-4F) . Moreover, the vacuolization phenotype was visualized in order to assess concomitant rescue. Intriguingly, only a partial rescue in phenotype was observed in VHL-mutated Crispr.Beclin-1 and Crispr.ATG5 cells, whilst no such rescue was observed in RCC4 VHL and HeLa (Fig.4A-4B and 4C-4F).
Taken together, these results indicate that while autophagy plays a role in STF-62247 signaling in VHL-mutated RCC4 cells, the persisting phenotype alludes to contributions from additional intimately linked pathways.
STF-62247 localizes at lysosomes and induces swelling of endocytic compartments
The auto-fluorescent property of STF was exploited to visualize its cellular localization. Colocalization studies by live cell imaging of STF and tagged RFP-Bacmam transduced cells was accomplished to visualize endo-lysosomal and endoplasmic reticulum (ER) compartments ( Fig.   5A, 5B ). More specifically, CellLight lysosomes-RFP (RFP-Lamp-1) and ER-RFP (RFPcalreticulin and -KDEL sequence) were utilized to transduce VHL-mutated RCC4 and RCC4 VHL cells. The fluorescence of STF appears as defined green fluorescent puncta in both RCC4 and RCC4 VHL cells ( Fig. 5A, 5B) . Following treatment, STF almost entirely co-localizes with LAMP-1 positive compartments in both VHL-mutated and -proficient cell models ( Fig. 5A-5B ).
Furthermore, the absence of STF fluorescent co-localization with ER compartments indicates that it does not bind randomly to a multitude of membrane-bound markers but is in fact specific to LAMP-1 positive structures (i.e. late endosomes and lysosomes) (Fig 5A, 5B) .
Lucifer Yellow (LY) is a well-known impermeable pH-insensitive marker of fluid phase endocytosis i.e pinocytosis/macropinocytosis; an endocytic mechanism for the non-specific bulk uptake and internalisation of extracellular fluid. (36) (37) (38) (39) (40) (41) (42) Considering that LY can only enter the cell by being internalized, this dye was an ideal tool to highlight the endocytic route, leading to late endosomes and lysosomes. Thus, in order to confirm the endo-lysosomal nature of these enlarged vacuoles, STF-treated cells were stained with LY ( Fig. 5C, 5D) . In RCC4 and RCC4 VHL DMSO controls, LY dye enters cells and forms fluorescent puncta-like structures (Fig.   5C ). In STF-treated cells however, LY resides exclusively inside enlarged vacuoles confirming their endo-lysosomal origin (Fig. 5C) . Lysotracker red (LTR) is a widely used acidotropic dye for the visualization of acidic organelles.(43) Both VHL-mutated and -proficient RCC models were treated with STF and imaged by live-cell microscopy after co-staining with LY and LTR red (Fig. 5D) . The acidotropic LTR accumulates and decorates the limiting membranes of these LY-filled structures indicating possible deregulated fusion events between acidic compartments (Fig. 5D) . The inability of LTR to stain these swollen organelles would lead us to believe that they might not be acidic in nature and in fact be earlier endocytic compartments. However, in similar cases of endo-lysosomal disruption and enlargement, others have also documented the inability of LTR red to mark the lumen of these swollen late endosome and lysosomal acidic compartments. (44) (45) (46) Although blocking autophagy initiation through KOs of essential ATG genes significantly reduced RCC4 cells' sensitivity to STF, they were unable to rescue the vacuolization phenotype ( Fig. 4A-4F ). For these reason, we hypothesized that STF might target endocytic pathways and have repercussions on autophagy termination. And so, a widely-used inhibitor of endocytic pathways was used (i.e Dynasore) in combination with STF and visualized by inverted-light microscopy (Fig. 5E) . By visualizing VHL-mutated RCC4 cells as well as VHL-proficient RCC4 VHL and HeLa cell models, no changes in the cells' appearance were documented in response to DYN treatment alone (Fig. 5E) . As shown, treatment with STF immediately caused the swelling of endo-lysosomal compartments in all three cell models (Fig. 5E) . However, when a simultaneous DYN treatment was added to STF, vacuolization was completely prevented and did not occur, resulting in a complete rescue of STF's effect (Fig. 5E) . Altogether, these results show that STF localizes at LAMP-1 positive structures (late-endosomes and lysosomes) and affects endocytosis through enlargement of endo-lysosomal structures.
STF-62247 possesses lysosomotropic properties and affects lysosomal integrity and cathepsin D trafficking.
The localization of STF at lysosomal structures led us to hypothesize that this compound had lysosomotropic characteristics and the vacuolization phenotype could in fact originate from the swelling of acidic endo-lysosomal structures. Similar to LTR, acridine orange (AO) is another acidotropic dye (AO) that was used to visualize the acidity of these translucid vacuoles. The mechanism of action of this weak base metachromatic dye is better characterized than that of LTR and is known for its capacity to stain acidic organelles such as late endosomes and lysosomes. AO molecules become protonated and trapped and their accumulation inside these acidic endo-lysosomal structures leads to a shift in excitation from green to red (530nm to 620nm) thus, permitting the differentiation of acidic organelles (red-orange granules) from other cellular compartments (diffuse green).(53-55) Following a short-term STF treatment, AO staining revealed vivid red fluorescence as a result of its rapid accumulation inside the growing vacuoles present in VHL-mutated RCC4 cells (Fig. 6A) . No striking differences in the numbers of red granules were observed in STF-treated VHL-proficient cells compared to the DMSO control; concurrent with the modest vacuolization phenotype of these cells (Fig. 6A) .
Furthermore, BAF treatment was utilized as a specificity control for AO staining as it neutralizes endo-lysosomal pH via inhibition of the v-ATPase proton pump. As expected, BAF treatment alone eliminated the levels of red granules in both RCC4 and RCC4 VHL cell models (Fig. 6A) .
Moreover, the addition of BAF to STF treatment resulted in a complete loss of red fluorescence and seemed to rescue the endo-lysosomal swelling phenotype, indicating that STF could no longer have its effect when lysosomal pH was neutralized (Fig. 6A) . To differentiate a true rescue in the phenotype from a possible inability of these vacuoles to become acidic, inverted light microscope images were taken in both VHL-mutated RCC4 cells and RCC4 VHL (Fig.   6B ). The combination of BAF plus STF treatment completely inhibited the formation of STFinduced vacuoles resulting in a full phenotype rescue highlighting both the importance of the V-ATPase pump in STF's signaling and the compounds lysosomotropic properties (Fig. 6B) . AO staining was also performed at a later time point to see if the vacuoles retained their capacity to trap AO molecules (Fig. 6C, 6D) . Even at 72 hr of STF treatment, these extremely swollen compartments retained their acidity as AO molecules were still accumulating within them, getting protonated and emitting red fluorescence (Fig. 6C) . RCC4 VHL cells however, showed no differences in red granule staining in response to 72 hr of STF treatment (Fig. 6D) .
The observed enlargement of endo-lysosomal compartments should theoretically disrupt normal cellular vesicular trafficking. This hypothesis was tested by following the maturation of a wellknown lysosomal aspartyl protease Cathepsin D (CTSD) which has a step-wise maturation process; synthesized in the ER, transported to Golgi stacks, then to endosomes and becoming completely active in the lysosomal lumen ( Fig. 6E, 6F) . and cleaved/active CTSD (lysosomes)) in response to increasing concentrations of STF were performed (Fig. 6E) . Accumulation of pro-and intermediate-CTSD was observed in a concentration-dependent manner in both RCC4 and RCC4 VHL cell models (Fig. 6E) . Next, longer STF treatment-times were tested in all three cell line models (Fig. 6F) . In response to 24 hr and 48 hr of STF treatment, levels of active cleaved-CTSD were strikingly decreased with an accompanying accumulation of pro-and intermediate-CTSD in all three cell line models, highlighting the effect of STF on vesicular trafficking (Fig. 6F) . Taken together, these results show that swollen endo-lysosomal compartments retain their acidity in response to STF, even at 72 hr of STF treatment. Interestingly, the complete phenotype rescue observed with the combinatory treatment of BAF plus STF confirms lysosomotropic characteristics of STF.
Finally, the accumulation of immature cathepsin D shows that STF affects lysosomal integrity and vesicular trafficking concomitant with the measured block in later stages of autophagy.
DISCUSSION.
The present work is the first to identify clear mechanistic insights into STF-62247's effects on the autophagic flux and on its lysosomotropic properties. By utilizing several autophagic assays exploring both later stages of autophagy as well as important upstream signaling pathways leading to autophagy initiation, we show that STF-62247 is a clear blocker of later stages of autophagy through endocytic and vesicular trafficking deregulation and does not affect initiation of canonical AP formation.
Our results build on and enhance the comprehension of the original study that aimed at selectively targeting VHL-defective RCCs. (10) . Originally identified as an autophagy inducer, we re-classify STF-62247 as a potent blocker of autophagy through disruption of lysosomal physiology. Initially, identification of STF-62247 was accomplished by high-throughput screening of 64 000 synthetic compounds in ccRCC models (RCC4 and its subclone counterpart expressing wild-type VHL; RCC4 VHL). (10, 20, 21, 59) With this in mind, cell models for this study were chosen very carefully. The identical cell models were chosen for a more thorough and accurate characterization of STF-62247's effects on autophagy and its related signaling pathways. Moreover, HeLa cells were chosen as a control cell model for two reasons; firstly, because autophagy has been abundantly studied in this cell line and secondly, because it harbours endogenous wild-type VHL, differentiating it from the VHL over-expressing subclone RCC4 VHL.
By exploiting the natural auto-fluorescence of this small compound, we were able to pinpoint its cellular endo-lysosomal localization which leads to extreme enlargement of these structures in the VHL-mutated model. Unfortunately, even by localizing STF to LAMP-1 positive structures,
we have yet to identify its protein target. This insight would be greatly beneficial in understanding the exact cause of the endo-lysosomal swelling phenotype, something we are actively pursuing. Although autophagy blockage by STF-62247 is independent of VHL-status, it would seem that the acclimatization to this small compound (i.e. capacity of VHL-positive cells to surmount lysosomal swelling) is in fact dependent on this tumor suppressor. These results strongly suggest a possible unidentified role for VHL in the maintenance of lysosomal integrity.
Although this was not the objective of the present work, we highlighted the ability of VHLcontaining cells to surmount the STF-induced enlargement of late endosomes and lysosomes and renew their numbers (LAMP-1 positive structures) at a prolonged STF treatment time; something VHL-mutated cells were unable to do. In fact, mTOR re-activation has been shown to be an essential step for autophagic lysosomal reformation, a fascinating mechanism of lysosomal recycling and reformation where tubules and vesicles emanate from autolysosomes and mature into newly functional lysosomes. (60) (61) (62) During this process and after prolonged stress conditions (or starvation), the autolysosomal degradation of macromolecules triggers the reactivation of mTOR in order to replenish the number of lysosomes. While short-term STF treatment does not seem to affect mTOR phosphorylation, we have previously shown that prolonged treatment of STF decreases the phosphorylation levels and activity of mTOR in VHLdeficient cells, concomitant with an inability of these cells to renew LAMP-1 positive structures.
Moreover, in VHL-proficient cells, mTOR phosphorylation levels are returned to normal as compared to the DMSO control after prolonged STF treatment times.(34) These intriguing results merit further investigations as it is a possibility that the capability of VHL-proficient cells to surmount the endolysosomal swelling induced by STF-62247 could be linked to their ability to form new lysosomes. Elucidating these insights would help explain the toxicity differences observed between VHL-mutated and -functioning cells.
Autophagy has a multifaceted role in tumor evasion from immune surveillance and targeting its later stages shows great potential in ccRCCs. XTT viability assay.
XTT viability assays were performed as previously described. ( #P9625) ) was added to each well and plates were incubated at 37°C for 1 hr. Absorbance was then read at 450nm on a Spectramax
Plus spectrophotometer (Molecular Devices, Sunnyvale, CA).
Inverted-light microscopy imaging
Images of untreated and treated cells (vacuolization) were taken with a CoolPix990 Nikon camera (Nikon, Japan) mounted on a Nikon TMS-F inverted microscope (Nikon, Japan).
Western Blot analysis.
Western Blot were performed as previously described. (23, 34) Briefly, cells were lysed in M-PER buffer and quantified using Pierce BCA protein assay Kit (Thermo Scientific, #23225). 
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